Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 79 (4) , 243-250
- https://doi.org/10.1054/tuld.1999.0206
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in MalawiThe Lancet, 1996
- Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovisJournal of Bacteriology, 1996
- Adverse reactions in healthy and immunocompromised children under six years of age vaccinated with the Danish BCG vaccine, strain Copenhagen 1331: implications for the vaccination policy in SwedenActa Paediatrica, 1993
- Efficacy of BCG vaccine against leprosy and tuberculosis in northern MalawiThe Lancet, 1992
- Long-term complete remission inbladder carcinoma in situ with intravesical tice bacillus Calmette guerinUrology, 1991
- Changes in BCG strainsTubercle, 1983
- Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigsJournal of Biological Standardization, 1979
- Evaluation of BCG vaccines in children, the effect of strain and doseJournal of Biological Standardization, 1977
- BCG Vaccination in DenmarkPublic Health Reports (1896-1970), 1946